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Left Ventricular Thrombus Leading to Embolic Stroke in a Patient without Typical
Risk Factors
Abstract
Left ventricular thrombi are most commonly observed in patients after a myocardial infarction with left
ventricular aneurysm. We present a case of a 60 year old male who developed an embolic
cerebrovascular accident (CVA) secondary to a left ventricular thrombus without evidence of an
anteroapical aneurysm or diagnosed myocardial infarction. Outpatient investigation after hospitalization
for the acute CVA led to an eventual diagnosis of multiple myeloma. This case reinforces the importance
of considering rare etiologies including malignancy in patients who present without typical risk factors for
embolic disease.
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Introduction
The most common event leading to a left ventricular thrombus is an anterior ST elevation
myocardial infarction (MI) with anteroapical left ventricle aneurysm.1 Once developed, a left
ventricle thrombus then poses a significant risk of embolizing and leading to an embolic stroke.2
With advances in rapid revascularization following an MI, left ventricular thrombi have become
less common over time. Left ventricular thrombi used to occur in up to 60% of patients prior to
widespread use of percutaneous coronary intervention (PCI) however with PCI, prevalence of left
ventricular thrombi after an MI now occurs in about 5-15% of cases.3 Other common causes of
left ventricle thrombus include dilated cardiomyopathy, rheumatic heart disease, and peripartum
cardiomyopathy.3
Case Presentation
A 60 year old male who had not previously engaged in routine healthcare for the past several
decades presented to the emergency department with right sided weakness. He had no known
medical history and did not take any medications. He had no history of chest pain or dyspnea on
exertion. He did have a 45 pack per year smoking history. Family history included a mother
deceased from emphysema and father deceased for unknown reasons. Initial workup during his
hospitalization revealed a left middle cerebral artery thrombus and infarction of left caudate
nucleus and left insular cortex. The patient received tissue plasminogen activator and his
symptoms of right sided weakness gradually resolved over the course of a few hours. Standard
stroke workup included a transthoracic echocardiogram that demonstrated a left ventricular
thrombus with apical hypokinesis near the left ventricle apex. The patient reported no chest pain
or palpitations and his initial troponin level was normal but not followed up. An electrocardiogram
(EKG) showed sinus rhythm with heart rate of 80 bpm, T-wave inversions in anterolateral and
inferior leads. Prior EKG’s were unavailable for comparison and coronary angiogram was not
performed during the hospitalization. The patient was started on metoprolol, atorvastatin, and
warfarin with an enoxaparin bridge and discharged to home.
The patient received routine outpatient follow up care however at two months post
hospitalization, he reported a new concern of low back pain. The pain was right sided and the
patient reported that it started after a long day of work as a mechanic at a bowling alley. On exam,
the patient demonstrated a right lumbar paraspinal muscle spasm and he was treated with a short
course of cyclobenzaprine. The back pain persisted so further work up was performed including
labwork to assess baseline liver and kidney function. This lab work included a total protein was
shown to be elevated at 9.1 g/dL and a decreased albumin:globulin ratio of 0.7. The patient had
normal hemoglobin, hematocrit, and calcium levels. Given the overall picture, which included an
unexplained left ventricular thrombus and low back pain, a serum protein electrophoresis (SPEP)
level was obtained due to concern for possible multiple myeloma. The SPEP resulted with an IgG
lambda monoclonal spike. The patient was referred to oncology and a bone marrow biopsy
confirmed a diagnosis of multiple myeloma. He was started on chemotherapy treatment shortly
after, including zoledronic acid, carfilzomib, lenalidomide, and dexamethasone.
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Discussion
With this patient, we suspect that an underlying diagnosis of multiple myeloma contributed to his
LV thrombus. While MI with anteroapical left ventricle aneurysm is the most common cause of
LV thrombus, there are documented cases of patients developing LV thrombus related to
Takotsubo cardiomyopathy,4 Heparin-induced thrombocytopenia,5 Behcet disease,6 and
disseminated intravascular coagulation.7 The lack of chest pain and negative troponin levels, and
no ischemic EKG changes would argue against a MI. It is possible that a silent MI could have
resulted in the T wave inversion and left ventricular hypokinesis seen on echocardiogram, however
in the absence of an anteroapical left ventricle aneurysm it was appropriate to be open to other
possible causes of thrombus formation.
While we were unable to find another reported case of left ventricular thrombus related to
multiple myeloma, it is known that patients with multiple myeloma and IgG/IgA MGUS do show
a significantly increased risk of both arterial and venous thrombosis.8 The mechanism of
hypercoagulability in patients with multiple myeloma remains unknown, but it has been suggested
that ongoing clonal plasma cell activity is a potential cause.8 Despite the elevated risk of arterial
and venous thrombosis it is not common practice to place patients with multiple myeloma on
thromboprophylaxis outside of the treatment course described below. Our patient however, was
continued on warfarin given the known LV thrombus.
Preferred treatment for patients with symptomatic multiple myeloma is hematopoietic cell
transplantation (HCT) however this patient declined the procedure as he did not want to have it
done during the COVID 19 pandemic. For patients who are ineligible for HCT, triplet therapy is
the preferred initial treatment. Triplet therapy consists of a Thalidomide agent, steroid, and an
alkylating agent or an anthracycline. Some patients who are deemed too frail for triplet therapy
will often be treated with thalidomide and a steroid. Interestingly people on this treatment have
reported frequency of thrombotic events as high as 26%.9 All multiple myeloma patients receiving
combination therapy are recommended to be on routine VTE prophylaxis per the American Society
of Clinical Oncology.
Conclusion
Left ventricular thrombi have become rarer over time due to increased use of percutaneous
coronary angiography after MI. Other risk factors continue to exist for left ventricular thrombi
and thrombi in general. When patients present without typical risk factors for left ventricular
thrombi, it is important to consider some of the less common causes of thrombi including
malignancy.
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